Actively Recruiting
Russian Registry of Treatment of Venous Thromboembolism
Led by Medalp Private Surgery Clinic · Updated on 2025-05-08
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Medalp Private Surgery Clinic
Lead Sponsor
S
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research focuses on patients with venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, treated at various Russian medical centers. It aims to collect and update patient data in a digital registry to support future prospective randomized, cohort, and observational studies. The registry is managed by the Medalp Private Surgery Clinic and seeks to understand treatment outcomes and patient quality of life. Patients receive treatment through different approaches such as anticoagulants, thrombolysis, open surgery to remove blood clots, and venous stenting to relieve vein obstruction. These treatments are recorded in the registry as they are performed as part of routine care. The registry continuously collects data over time, including baseline and follow-up assessments at 3 and 12 months after procedures. Participants contribute by allowing their treatment and health data to be entered into the digital database. Researchers assess vein openness (patency), postthrombotic syndrome symptoms, and quality of life using SF-36 and AVVQ questionnaires at baseline, 3 months, and 12 months after intervention. This ongoing data collection helps monitor patient outcomes and supports future research. Participation duration varies depending on treatment and follow-up schedules.
CONDITIONS
Brief Title
Ongoing Registry of Treatment of Venous Thromboembolism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosed with venous thrombosis of a limb or pulmonary embolism
You will not qualify if you...
- No exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months post-intervention
Participants who undergo routine care are observed for outcomes related to venous thromboembolism treatment.
Visits at baseline, 3 months, and 12 months post-intervention
Trial Site Locations
Total: 1 location
1
Pirogov Russian National Research Medical University
Moscow, Moscow, Russia, 190000
Actively Recruiting
Research Team
E
Evgeny Ilyukhin
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here